Inhibition of Human α-Thrombin with Small Covalent Inhibitors and r-Hirudin
نویسنده
چکیده
Thrombin is a key serine protease involved in the blood cascade. Two small molecular inhibitors, 4-nitrophenyl diethylphosphate (paraoxon) and 4-nitrophenyl 2-propyl methylphosphonate (MPNP), covalently bond to the active-site Ser to form a mimic of the tetrahedral intermediate found in thrombin-catalyzed reactions. The pH dependence of their inhibition of human α-thrombin at 25.0 + 0.1C was determined. The pKa1 and pKa2 for paraoxon are 7.8 ± 0.1 and 9.3 ± 0.2 respectively, and for MPNP are 8.0 ± 0.1 and 8.6 ± 0.2 respectively. The pKas may be attributed to the role of His57 and Leu16 respectively in catalysis. The maximal second order rate constant, ki/Ki, for the inhibition of human α-thrombin was determined to be 0.47 ± 0.05 Ms with paraoxon and 6.2 ± 0.1 Ms with MPNP. Hirudin, found naturally in Hirudo medicinalis, is a slow and tight binding inhibitor of thrombin, interacting noncovalently over a large area. This study focused on the dependence of this interaction on the presence of Na and Cl ions at an ionic strength () of 0.3 M. Kinetic measurements were conducted spectrophotometrically in the presence of the chromophoric substrate, H-D-Phe-Pip-Arg-4-nitroanilide. The dissociation constant and second-order rate constant, when fitted, for the inhibition of human -thrombin with r-hirudin at pH ~ 8.1 and 25.0 + 0.1 C are: (0.47 + 0.15) pM and (4.8 ± 0.1) x 10 Ms in NaCl; (2.8 ±0.1) pM and (3.49 + 0.02) x 10 Ms in Na acetate; (13.8 ± 0.2) pM and (8.2 ± 0.4) x 10 M s in choline Cl; (12 ± 3) pM in choline acetate. The solvent isotope effect, KH/KD, for Ki is 0.26 + 0.15 in NaCl; 0.72 + 0.02 in Na acetate; 2.1 + 0.5 in choline acetate; and 2.59 + 0.03 in choline chloride. This suggests that the association of hirudin with thrombin is accompanied with changes in hydrogen bonding as a function of Na and Cl ions.
منابع مشابه
Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.
Thrombus extension in patients with venous thromboembolism is due to the accretion of fibrin onto existing thrombi. Extension is promoted by both circulating and thrombus-bound thrombin, which convert fibrinogen to fibrin. Heparin is an effective antithrombotic agent, but it requires continuous administration to achieve persistent inhibition of thrombus extension. Heparin is highly effective in...
متن کاملProlonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries.
BACKGROUND Arterial injury after percutaneous transluminal coronary angioplasty (PTCA) triggers acute thrombus formation and thrombin generation. Hirudin, a potent and direct thrombin inhibitor, prevents thrombus formation after arterial injury. Two large clinical trials showed marked reduction in acute clinical events but no long-term benefits in reducing restenosis during short-term administr...
متن کامل[New anticoagulants for secondary haemostasis--anti IIa inhibitors].
In contrast to heparins and oral anticoagulants, anti IIa inhibitors (thrombin inhibitors) are able to directly inhibit the protease activity of thrombin and can thereby precisely control the blood coagulation process. Direct thrombin inhibitors are either biosimilars (r-hirudin) or synthetically produced substances (bivalirudin, argatroban, dabigatran). In 1997 r-hirudin was introduced into cl...
متن کاملEffects of ximelagatran, an oral direct thrombin inhibitor, r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects.
OBJECTIVES The effects of ximelagatran, an oral direct thrombin inhibitor (DTI), recombinant hirudin (r-hirudin) and enoxaparin on thrombin generation and platelet activation were studied in humans. BACKGROUND Recombinant hirudin (parenteral DTI) and enoxaparin (low molecular weight heparin) have been demonstrated to be clinically effective in acute coronary syndromes. Ximelagatran is current...
متن کاملDynamic thrombosis and thrombolysis. Role of antithrombins.
In vivo thrombosis after deep arterial injury has been experimentally shown by receptor inhibitors to be mediated predominantly by thrombin activation of platelets and to a lesser extent by thrombin-related fibrin formation. Thrombosis and thrombolysis are dynamic and simultaneous processes that may influence each other, depending on the exposure and concentration of thrombin and administered a...
متن کامل